Kim Kelderman
Director; Director, Chief Executive Officer · 8 filings · Latest: Sep 8, 2026
BIO-TECHNE Corp
CONMED Corp
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
CNMD | Kim Kelderman | Director | Sep 8, 2026 | Option Exercise | $0.00 | 500 | — | 500 | |
TECH | Kim Kelderman | Director, Chief Executive Officer | Aug 15, 2026 | Option Exercise | $0.00 | 21,470 | — | 93,583 | |
TECH | Kim Kelderman | Director, Chief Executive Officer | Jul 28, 2026 | Option Exercise | $47.60 | 35,000 | $1.7M | 100,799 | |
TECH | Kim Kelderman | Director, Chief Executive Officer | May 5, 2026 | Option Exercise | $47.60 | 26,692 | $1.3M | 89,750 | |
TECH | Kim Kelderman | Director, Chief Executive Officer | Apr 22, 2026 | Option Exercise | $0.00 | 11,344 | — | 64,421 | |
TECH | Kim Kelderman | Director, Chief Executive Officer | Apr 14, 2026 | Option Exercise | $0.00 | 36,500 | — | 85,165 | |
TECH | KIM KELDERMAN | — | Jan 27, 2025 | Proposed Sale | $77.05 | 13,392 | $1.0M | — |